Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Cited by (1,004)

Items 101–200 of 1,004

1. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
   Arvinder Singh Soin, Kuldeep Kumar, Narendra Singh Choudhary, Pooja Sharma, Yatin B. Mehta, Sushila Kataria, Deepak Govil, Vikas Deswal, Dhruva Chaudhry, Pawan Kumar Singh et al. · 2021 · The Lancet Respiratory Medicine
2. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases
   Rita M. Meganck, Ralph Steven Baric · 2021 · Nature Medicine
3. Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
   Dharma Rao Tompa, Aruldoss Immanuel, Srimari Srikanth, Kadhirvel Saraboji · 2021 · International Journal of Biological Macromolecules
4. SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
   Lars F. Westblade, Gagandeep Singh Brar, Laura C. Pinheiro, Demetrios Paidoussis, Mangala Rajan, Peter Martin, Parag Goyal, Jorge L. Sepulveda, Lisa Zhang, Gary George et al. · 2020 · Cancer Cell
5. Long term respiratory complications of covid-19
   Emily Fraser · 2020 · BMJ
6. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
   Jim Baggen, Leentje Persoons, Els Vanstreels, Sander Jansen, Dominique Van Looveren, Bram Boeckx, Vincent Geudens, Julie De Man, Dirk Jochmans, Joost Wauters et al. · 2021 · Nature Genetics
7. Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review
   Mukhtar H. Ahmed, Arez Hassan · 2020 · SN Comprehensive Clinical Medicine
8. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
   Richard J. Mills, Sean J. Humphrey, Patrick R.J. Fortuna, Mary Lor, Simon Richard Foster, Gregory A. Quaife-Ryan, Rebecca L. Johnston, Troy D. Dumenil, Cameron Bishop, Rajeev Rudraraju et al. · 2021 · Cell
9. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
   Jordan J. Feld, Christopher E. Kandel, Mia J. Biondi, Robert Andrew Kozak, Muhammad Atif Zahoor, Camille Lemieux, Sergio M. Borgia, Andrea K. Boggild, Jeff E. Powis, Janine McCready et al. · 2021 · The Lancet Respiratory Medicine
10. Host genetics and infectious disease: new tools, insights and translational opportunities
    Andrew John Kwok, Alexander J. Mentzer, Julian Charles Knight · 2020 · Nature Reviews Genetics
11. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
    Thomas M Drake, Annemarie Beth Docherty, Ewen Munro Harrison, Jennifer Kathleen Quint, Huzaifa I. Adamali, Sarah Agnew, Suresh Babu, Christopher Michael Barber, Shaney Louise Barratt, Elisabeth M. Bendstrup et al. · 2020 · American Journal of Respiratory and Critical Care Medicine
12. Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
    Patrícia Figueiredo‐Campos, Birte Blankenhaus, Catarina Mota, Andréia Gomes, Marta Serrano, Silvia Ariotti, Catarina Januária Mendes da Costa, Helena Nunes‐Cabaço, António M. Mendes, Pedro Gaspar et al. · 2020 · European Journal of Immunology
13. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
    Awadhesh Kumar Singh, Sujoy Majumdar, Ritu Singh, Anoop Misra · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
14. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome
    Zesemayat K. Mekonnen, Davin C. Ashraf, T. Jankowski · 2020 · Ophthalmic Plastic and Reconstructive Surgery
15. Preliminary predictive criteria for COVID-19 cytokine storm
    Caricchio, Roberto, Gallucci, Marcello, Dass, Chandra, Zhang, Xinyan, Gallucci, Stefania, Fleece, David, Bromberg, Michael, Criner, Gerard J · 2021 · Annals of the Rheumatic Diseases
16. Cognitive impact of COVID-19: looking beyond the short term
    James Scott Miners, Patrick G. Kehoe, Seth Love · 2020 · Alzheimer s Research & Therapy
17. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
    Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone, Sonia C. Youhanna, Peter J. Richardson, Silvia Ottaviani, Joanne X. Shen, Christian Sommerauer, Giusy Tiseo, Lorenzo Ghiadoni et al. · 2020 · Science Advances
18. Methodological quality of COVID-19 clinical research
    Jung, Richard G., Di Santo, Pietro, Clifford, Cole, Prosperi-Porta, Graeme, Skanes, Stephanie, Hung, Annie, Parlow, Simon, Visintini, Sarah, Ramirez, F. Daniel, Simard, Trevor et al. · 2021 · Nature Communications
19. Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
    Giuseppina Mariano, Rebecca J. Farthing, Shamar L. M. Lale-Farjat, Julien R. C. Bergeron · 2020 · Frontiers in Molecular Biosciences
20. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
    Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, Jacqueline Sneddon, Ronald Andrew Seaton, Adesola F. Yinka-Ogunleye, Joshua Wamboga, Nenad Miljković, Julius Chacha Mwita, Godfrey Mutashambara Rwegerera et al. · 2020 · Frontiers in Pharmacology
21. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
    Kyung Mok Sohn, Sung‐Gwon Lee, Hyeon Ji Kim, Shinhye Cheon, Hyeongseok Jeong, Joo-Yeon Lee, In Soo Kim, Prashanta Silwal, Young Jae Kim, Seungwha Paik et al. · 2020 · Journal of Korean Medical Science
22. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
    Thieme, Constantin J., Anft, Moritz, Paniskaki, Krystallenia, Blazquez-Navarro, Arturo, Doevelaar, Adrian, Seibert, Felix S., Hoelzer, Bodo, Konik, Margarethe Justine, Berger, Marc Moritz, Brenner, Thorsten et al. · 2020 · Cell Reports Medicine
23. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study
    Rishi K Gupta, Michael Marks, Thomas H. A. Samuels, Akish Luintel, Tommy Rampling, Humayra Chowdhury, Matteo Quartagno, Arjun Nair, Marc C.I. Lipman, Ibrahim Abubakar et al. · 2020 · European Respiratory Journal
24. Phenotypes and personalized medicine in the acute respiratory distress syndrome
    Michael A. Matthay, Yaseen M. Arabi, Emily R. Siegel, Lorraine B. Ware, Lieuwe D. J. Bos, Pratik Sinha, Jeremy R. Beitler, Katherine D. Wick, Martha A. Q. Curley, Jean‐Michel Constantin et al. · 2020 · Intensive Care Medicine
25. NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
    Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, Willm T. Heyken, Matthias Ocker, Oliver Planz · 2020 · Frontiers in Immunology
26. Dexamethasone in the management of covid -19
    Raymond M. Johnson, Joseph Michael Vinetz · 2020 · BMJ
27. COVID-19 and myocarditis: a systematic review and overview of current challenges
    Teresa Castiello, Georgios A. Georgiopoulos, Gherardo Finocchiaro, Monaco Claudia, Andrea Gianatti, Dimitrios Delialis, Alberto Aimo, Sanjay Kumar Prasad · 2021 · Heart Failure Reviews
28. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
    Sujan Kumar Dhar, K. Vishnupriyan, Sharat Damodar, Shashi Ashok Gujar, Manjula Das · 2021 · Heliyon
29. Systemic corticosteroids for the treatment of COVID-19
    Carina Wagner, Mirko Griesel, Agata Mikołajewska, Anika Mueller, Monika Nothacker, Karoline Kley, Maria‐Inti Metzendorf, Anna-Lena Fischer, Marco Kopp, Miriam Songa Stegemann et al. · 2021 · Cochrane Database of Systematic Reviews
30. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases
    Meng–Huang Wu, Yaobing Chen, Han Xia, Changli Wang, Chin Yee Tan, Xunhui Cai, Yufeng Liu, Fenghu Ji, Xiong Peng, Ran Liu et al. · 2020 · Proceedings of the National Academy of Sciences
31. Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
    Katerina Pyrillou, Laura C. Burzynski, Murray C.H. Clarke · 2020 · Frontiers in Immunology
32. Sex differences in COVID-19: the role of androgens in disease severity and progression
    Mohamed S. Mohamed, Thiago C. Moulin, Helgi B. Schiöth · 2020 · Endocrine
33. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
    M. Hoffmann, Heike Hofmann-Winkler, Joan C. Smith et al. · 2020 · bioRxiv
34. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
    Sobia Noreen, Irsah Maqbool, Asadullah Madni · 2021 · European Journal of Pharmacology
35. The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
    Lauren A. Callender, Michelle Curran, Stephanie M. Bates, Maelle Mairesse, Julia Weigandt, Catherine Jean Betts · 2020 · Frontiers in Immunology
36. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
    Byung‐Chul Lee, Insung Kang, Kyung–Rok Yu · 2021 · Journal of Clinical Medicine
37. Corticosteroids in COVID-19 ARDS
    Hallie C. Prescott, Todd W. Rice · 2020 · JAMA
38. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China
    Zhilin Zeng, Haijing Yu, Huilong Chen, Weipeng Qi, Liang Chen, Guang Chen, Weiming Yan, Tao Chen, Qin Ning, Meifang Han et al. · 2020 · Critical Care
39. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
    Min Seo Kim, Min Ho An, Won Jun Kim, Tae-Ho Hwang · 2020 · PLoS Medicine
40. Factors leading to high morbidity and mortality of COVID ‐19 in patients with type 2 diabetes
    Aman Rajpal, Leili Rahimi, Faramarz Ismail‐Beigi · 2020 · Journal of Diabetes
41. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
    Miguel Alejandro Pinzón, Santiago Ortiz, Héctor Holguín, Juan Felipe Betancur, Doris Cardona Arango, Henry Laniado, Carolina Arias Arias, Bernardo Muñoz, Julián Quiceno, Daniel Jaramillo et al. · 2021 · PLoS ONE
42. How COVID-19 has fundamentally changed clinical research in global health
    Jay Park, Robin Mogg, Gerald E Smith, Etheldreda Nakimuli‐Mpungu, Fyezah Jehan, Craig R. Rayner, Jeanine Umutesi Condo, Eric H. Decloedt, Jean Bisimwa Nachega, Gilmar Reis et al. · 2021 · The Lancet Global Health
43. Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19
    Patrick Holford, Anitra C. Carr, Thomas Harry Jovic, Stephen R Ali, Iain Stuart Whitaker, Paul Ellis Marik, Adrian D. Smith · 2020 · Nutrients
44. Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic
    John P. A. Ioannidis · 2020 · European Journal of Clinical Investigation
45. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
    Isabelle Bernard, Daniel Limonta, Lara K. Mahal, Tom C. Hobman · 2020 · Viruses
46. Worldwide Survey of COVID-19–Associated Arrhythmias
    Ellie J. Coromilas, Stephanie Kochav, Isaac L. Goldenthal, Angelo Biviano, Hasan Garan, Seth Goldbarg, Joon-Hyuk Kim, Ilhwan Yeo, Cynthia M. Tracy, Shant Ayanian et al. · 2021 · Circulation Arrhythmia and Electrophysiology
47. Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
    Prashant Nasa, Élie Azoulay, Ashish Kumar Khanna, Ravi Jain, Sachin Gupta, Yash Javeri, Deven Juneja, Pradeep Rangappa, Krishnaswamy Sundararajan, Waleed A. Alhazzani et al. · 2021 · Critical Care
48. Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
    Djillali Annane, Nicholas Heming, Lamiae Grimaldi‐Bensouda, Véronique Frémeaux‐Bacchi, Marie Vigan, Anne-Laure Roux, Armance Marchal, Hugues Michelon, Martin Rottman, Pierre Moine · 2020 · EClinicalMedicine
49. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
    Shuofeng Yuan, Runming Wang, Jasper Fuk‐Woo Chan, Jinxia Zhang, Tianfan Cheng, Kenn Ka‐Heng Chik, Zi‐Wei Ye, Suyu Wang, Andrew Chak-Yiu Lee, Lijian Jin et al. · 2020 · Nature Microbiology
50. Dexamethasone nanomedicines for COVID-19
    Twan Lammers, Alexandros Marios Sofias, Roy van der Meel, Raymond Michel Schiffelers, Gert Storm, Frank Tacke, Steffen Koschmieder, Tim H. Brümmendorf, Fabian M. Kiessling, Josbert M. Metselaar · 2020 · Nature Nanotechnology
51. COVID-19 and mucormycosis superinfection: the perfect storm
    Jaffar A. Al‐Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, Mohamad-Hani A. Temsah, Mazin Adnan Barry, Abbas Saleh Al Mutair, Ali Ahmed Rabaan, Awad Al‐Omari, Raghavendra Tirupathi, Manaf AlQahtani et al. · 2021 · Infection
52. Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda
    Andrew Marvin Kanyike, Ronald Olum, Jonathan Kajjimu, Daniel Ojilong, Gabriel Madut Akech, Dianah Rhoda Nassozi, Drake Agira, Nicholas Kisaakye Wamala, Asaph Asiimwe, Dissan Matovu et al. · 2021 · Tropical Medicine and Health
53. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
    Grigoris Gerotziafas, M. Catalano, Mary Paula Colgan, Zsolt Pécsvárady, Jean Claude Wautrecht, Bahare Fazeli, Dan-Mircea Olinic, Katalin Farkas, Ismaı̈l Elalamy, Anna Falanga et al. · 2020 · Thrombosis and Haemostasis
54. Azithromycin in viral infections
    Madeleine Oliver, Timothy Hinks · 2020 · Reviews in Medical Virology
55. Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial
    Fernando Godinho Zampieri, Jonathan Dale Casey, Manu Shankar‐Hari, Frank E. Harrell, Michael Oscar Harhay · 2020 · American Journal of Respiratory and Critical Care Medicine
56. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
    Alessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò, Marco Frigeni, Gianmaria Borleri, Anna Salvi, Francesco Landi, Chiara Pavoni, Aurelio Sonzogni, Andrea Gianatti et al. · 2020 · Immunobiology
57. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
    Arvind Gharbharan, Carlijn C. E. Jordans, Corine H. GeurtsvanKessel, Jan G. den Hollander, Faiz Karim, Femke P. N. Mollema, Janneke E. Stalenhoef, Anthonius S. M. Dofferhoff, Inge Ludwig, Adrianus Koster et al. · 2021 · Nature Communications
58. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
    Tobias Boettler, Thomas Marjot, Philip Noel Newsome, Mario Umberto Mondelli, Mojca Matičič, Elisa Cordero, Rajiv Jalan, Richard Moreau, Markus Cornberg, Thomas Berg · 2020 · JHEP Reports
59. Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies
    R. A. Armstrong, Andrew D. Kane, Emira Kursumovic, Fiona C. Oglesby, T. M. Cook · 2021 · Anaesthesia
60. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
    Brian Thomas Garibaldi, Kunbo Wang, Matthew L. Robinson, Scott L. Zeger, Karen Bandeen‐Roche, Mei‐Cheng Wang, G. Caleb Alexander, Amita Gupta, Robert C. Bollinger, Yanxun Xu · 2021 · JAMA Network Open
61. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes
    Edison Cano Cevallos, Xavier Fonseca Fuentes, Cristina Corsini Campioli, John Charles O’Horo, Omar Abu Saleh, Yewande Odeyemi, Hemang Yadav, Zelalem Temesgen · 2020 · CHEST Journal
62. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
    Ruirong Chen, Zhien Lan, Jujian Ye, Limin Pang, Yi Liu, Wei Wu, Xiaohuan Qin, Yang Guo, Peidong Zhang · 2021 · Frontiers in Immunology
63. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection
    Fiachra Humphries, Liraz Shmuel-Galia, Zhaozhao Jiang, Ruth Wilson, Philip Landis, Sze‐Ling Ng, Krishna Mohan Parsi, René Maehr, John Cruz, Ángel I. Morales-Ramos et al. · 2021 · Science Immunology
64. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
    Chris R. Triggle, Devendra Bansal, Hong Ding, Md. Mazharul Islam, Elmoubasher Farag, Hamad Abdel Hadi, Ali A. Sultan · 2021 · Frontiers in Immunology
65. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
    Woon Hean Chong, Biplab Kumar Saha, Ananthakrishnan Ramani, Amit Chopra · 2021 · Infection
66. Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
    Francesco Salton, Paola Confalonieri, Gianfranco Umberto Meduri, Pierachille Santus, Sergio Alfonso Harari, Raffaele Scala, Simone Lanini, Valentina Vertui, Tiberio Oggionni, Antonella Caminati et al. · 2020 · Open Forum Infectious Diseases
67. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
    Pranesh Padmanabhan, Rajat Desikan, Narendra M. Dixit · 2020 · PLoS Computational Biology
68. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
    Erin F. Balcom, Avindra Nath, Christopher Power · 2021 · Brain
69. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment
    Jeremy C. McMurray, Joseph W. May, Madeleine White Cunningham, Olcay Y. Jones · 2020 · Frontiers in Pediatrics
70. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
    Aaron Z Reyes, Kelly A. Hu, Jacob Teperman, Theresa Wampler Muskardin, Jean‐Claude Tardif, Binita Shah, Michael H. Pillinger · 2020 · Annals of the Rheumatic Diseases
71. Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes
    Weijian Hang, Chen Chen, John M. Seubert, Dao Wen Wang · 2020 · Signal Transduction and Targeted Therapy
72. In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
    Agnieszka M. Szemiel, Andres Merits, Richard J Orton, Oscar A. MacLean, Rute Maria Pinto, Arthur Wickenhagen, Gauthier Lieber, Matthew L. Turnbull, Sainan Wang, Wilhelm Furnon et al. · 2021 · PLoS Pathogens
73. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
    Johannes Korth, Michael Jahn, Oliver Dorsch, Olympia Evdoxia Anastasiou, Burkhard Sorge-Hädicke, Ute Eisenberger, Anja Gäckler, Ulf Dittmer, Oliver Witzke, Benjamin Wilde et al. · 2021 · Viruses
74. Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
    Daniele Focosi, Fabrizio Maggi · 2021 · Reviews in Medical Virology
75. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
    Miquéias Lopes‐Pacheco, Pedro Leme Silva, Fernanda Ferreira Cruz, Denise Battaglini, Chiara Robba, Paolo P. Pelosi, Marcelo Marcos Morales, Celso Caruso Neves, Patrícia R. M. Rocco · 2021 · Frontiers in Physiology
76. COVID-19 and Acute Sarcopenia
    Carly Welch, Carolyn Anne Greig, Tahir Masud, Daisy V. Wilson, Thomas Jackson · 2020 · Aging and Disease
77. Coronavirus-induced myocarditis: A meta-summary of cases
    Jamie Sin Ying Ho, Ching‐Hui Sia, Mark Y. Chan, Weiqin Lin, Raymond Ching-Chiew Wong · 2020 · Heart & Lung
78. Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
    Janet Sultana, Paola Maria Cutroneo, Salvatore Crisafulli, Gabriele Puglisi, Gaetano Caramori, Gianluca Trifirò · 2020 · Drug Safety
79. Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned
    Ryabkova, Varvara A., Churilov, Leonid P., Shoenfeld, Yehuda · 2021 · Clinical Immunology
80. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report
    Amirreza Veisi, Abbas Bagheri, M Eshaghi, Mohamad Hasan Rikhtehgar, Mozhgan Rezaei Kanavi, Reza Farjad · 2021 · European Journal of Ophthalmology
81. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention
    John P. Hussman · 2020 · Frontiers in Pharmacology
82. The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation
    Piotr Rzymski, Leszek Borkowski, Marcin Drąg, Robert Flisiak, Jacek Jemielity, Jacek Krajewski, Agnieszka Mastalerz–Migas, Andrzej Matyja, Krzysztof Pyrć, Krzysztof Adam Simon et al. · 2021 · Vaccines
83. Deciphering the state of immune silence in fatal COVID-19 patients
    Pierre Bost, Francesco De Sanctis, Stefania Canè, Stefano Ugel, Katia Donadello, Monica Castellucci, Eyal David, Alessandra Fiore, Cristina Anselmi, Roza Maria Barouni et al. · 2021 · Nature Communications
84. Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections
    Christine J. Kubin, Thomas Howe McConville, Donald Dietz, Jason E Zucker, Michael S. May, Brian C. Nelson, Elizabeth Istorico, Logan Bartram, Jennifer L. Small-Saunders, Magdalena E. Sobieszczyk et al. · 2021 · Open Forum Infectious Diseases
85. Retinal vein occlusion in COVID-19: A novel entity
    Jay Umed Sheth, Raja Narayanan, Jay Goyal, Vinod Goyal · 2020 · Indian Journal of Ophthalmology
86. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida
    Eduardo Oliveira, Amay Parikh, ARNALDO FABIAN LOPEZ‐RUIZ, Maria Carrilo, Joshua Goldberg, Martin Cearras, Khaled Fernainy, Sonja Andersen, Luis Mercado, Jian Guan et al. · 2021 · PLoS ONE
87. Pathogenesis of Respiratory Viral and Fungal Coinfections
    Fabián Salazar, Elaine Bignell, Gordon D. Brown, Peter C. Cook, Adilia Warris · 2021 · Clinical Microbiology Reviews
88. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation
    Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, Vahid Davoudi, Fatemeh Hajighasemi, Mehdi Ghasemi · 2020 · Journal of Neuroimmunology
89. Management of immune thrombocytopenia during COVID-19 pandemic
    S. V. Semochkin, T. Mitina, T. Tolstykh · 2021 · Russian journal of hematology and transfusiology
90. COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options
    Larissa E. van Eijk, Mathijs Binkhorst, Arno R. Bourgonje, Annette K. Offringa, Douwe Johannes Mulder, Eelke Marijn Bos, Nikola Kolundžić, Amaal Eman Abdulle, Peter H. J. van der Voort, Marcel G. M. Olde Rikkert et al. · 2021 · The Journal of Pathology
91. Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
    Baranca Buijsers, Cansu Yanginlar, Marissa L. Maciej-Hulme, Quirijn de Mast, Johan van der Vlag · 2020 · EBioMedicine
92. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
    Alfred Bentsi Addison, Billy L. K. Wong, Tanzime Ahmed, Alberto Macchi, Iordanis Konstantinidis, Caroline Huart, Johannes Frasnelli, Alexander Wieck Fjældstad, Vijay R. Ramakrishnan, Philippe Rombaux et al. · 2021 · Journal of Allergy and Clinical Immunology
93. COVID-19: In the Eye of the Cytokine Storm
    Roberto de la Rica, Marcío Borges-Sa, Marta González‐Freire · 2020 · Frontiers in Immunology
94. COVID-19: Pulmonary and Extra Pulmonary Manifestations
    Islam Hussam Elrobaa, Karl James New · 2021 · Frontiers in Public Health
95. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
    Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis, Miltiades Kyprianou, Carolin Fleischmann-Struzek, Mathias Wilhelm Pletz, Mihai Gheorghe Netea, Konrad Reinhart, Evdoxia Kyriazopoulou · 2021 · Critical Care Medicine
96. Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial
    Xiao Tang, Yingmei Feng, Ji-Xiang Ni, Jia-Ying Zhang, Li-Min Liu, Ke Hu, Xiu‐Zhi Wu, Ji-Xian Zhang, Jun-Wen Chen, Jian-Chu Zhang et al. · 2021 · Respiration
97. Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia
    Ivan O. Rosas, N. Bräu, Michael Waters et al. · 2020 · medRxiv
98. Bacterial infections and patterns of antibiotic use in patients with COVID‐19
    Alvaro Goncalves Mendes Neto, Kevin Bryan Lo, Ammaar Wattoo, Grace Salacup, Jerald Pelayo, Robert DeJoy, Ruchika Bhargav, Fahad Gul, Eric L. Peterson, Jeri Albano et al. · 2020 · Journal of Medical Virology
99. Clonal expansion and activation of tissue-resident memory-like T H 17 cells expressing GM-CSF in the lungs of patients with severe COVID-19
    Yu Zhao, Christoph Kilian, Jan‐Eric Turner, Lidia Bosurgi, Kevin Roedl, Patricia Bartsch, Ann-Christin Gnirck, Filippo Cortesi, Christoph Schultheiß, Malte Hellmig et al. · 2021 · Science Immunology
100. SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
     Ryan P. Chang, Abrar Mamun, Abishai Dominic, Nhat‐Tu Le · 2021 · Frontiers in Physiology